Knott David M Jr Adma Biologics, Inc. Transaction History

Knott David M Jr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$3.01 - $3.87 $163,015 - $209,591	-54,158 Reduced 40.94%	78,143 $259,000
Q4 2022 Feb 13, 2023	SELL	$2.47 - $3.88 $49,400 - $77,600	-20,000 Reduced 13.13%	132,301 $513,000
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.66 $166,008 - $252,819	152,301 New	152,301 $215,000

317

189M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.23B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.